Updates

First patient enrolled in Netherlands as part of global phase 3 trial of gonorrhoea treatment
26 Jun 2020

First patient enrolled in Netherlands as part of global phase 3 trial of gonorrhoea treatment

The Global Antibiotic Research and Development Partnership (GARDP) and Entasis Therapeutics announced today the first patient in the Netherlands has been enrolled as part of a global phase 3 pivotal trial of zoliflodacin.

Read more
We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.